Algoclinic
ActiveSummary
Algoclinic has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,101 and a net result of €2,101. Its solvency ranks better than 20% of 20,598 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
- Equity
- €3,101
- Profit
- €2,101
Why 91raises riskFounded in 2024lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.25, cash €6,468Figures for financial year 2025 (filed 29-04-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 20% on solvency, 36% on liquidity and 36% on profitability.
The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Searched, nothing found (1)
- General meeting · Other provisionName change · Registered-office move…
- Appointment: Florian Demuynck (additional director)Gazette deed
- Annual accounts filedfinancial year 2025 · micro…
Financials · financial year 2025, micro format
Turnover and EBIT margin not published: the micro format does not require them.
Peer companies
Historical observationOf the 7,976 companies that looked in July 2024 the way this one looks now, 3.6% went bankrupt within 24 months and 94.3% are still going.
- Micro
- 2 to 5 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
A further 0.3% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 7,976 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2025 |
|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,652 |
| Gross operating margin9900 | €6,509 |
| Operating profit (loss)9901 | €4,856 |
| Financial charges65/66B | €861 |
| Recurring financial charges65 | €861 |
| Profit (loss) for the period before taxes9903 | €3,996 |
| Income taxes67/77 | €1,895 |
| Profit (loss) for the period9904 | €2,101 |
| Profit (loss) for the period to be appropriated9905 | €2,101 |
| Line | 2025 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €15,756 | |
| Fixed assets21/28 | €821 | |
| Tangible fixed assets22/27 | €821 | |
| Plant, machinery and equipment23 | €821 | |
| Current assets29/58 | €14,935 | |
| Cash at bank and in hand54/58 | €6,468 | |
| Deferred charges and accrued income490/1 | €8,467 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €15,756 | |
| Equity10/15 | €3,101 | |
| Contributions10/11 | €1,000 | |
| Reserves13 | €2,101 | |
| Distributable reserves133 | €2,101 | |
| Amounts payable17/49 | €12,656 | |
| Amounts payable within one year42/48 | €11,986 | |
| Trade debts44 | €2,602 | |
| Suppliers440/4 | €2,602 | |
| Taxes, remuneration and social security45 | €2,925 | |
| Taxes450/3 | €2,925 | |
| Other amounts payable47/48 | €6,459 | |
| Accrued charges and deferred income492/3 | €670 | |
| Line | 2025 |
|---|---|
| Profit (loss) for the period9904 | €2,101 |
| + Depreciation and write-downs630 | €1,652 |
| Operating cash flow (approximation) | €3,753 |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (1)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 30-09-2025 | micro format | 29-04-2026 | 2026-00098190 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| VAN DEN BERGE Wouter |
|
| Florian Demuynck |
|
Owners and capital
Capital and shareholders
- VAN DEN BERGE Wouter 50 shares (100%)
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 27-06-2024 Incorporation · €1,000 · 50 shares
Group and network
Connections & network
2 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
Algoclinic was incorporated on 25 June 2024 as a private limited company by one natural person, with a starting capital of €1,000.12 In 2026 the company took the name Algoclinic.3 The registered office was moved to Zwevegem in 2026.3 The board currently has 2 members; VAN DEN BERGE Wouter has served longest, since 2024.2
Acts, filings and financial milestones
22-10
Gazette deed
General meeting · Other provisionName change · Registered-office move · Power of attorney6 facts ▸
- General meeting, buitengewone algemene vergadering, 05-10-2026
- Other provision, registerinschrijving, rechtspersonenregister Gent,afdeling Kortrijk
- Name change, Algoclinic
- Registered-office move, Oude Lettenhofstraat 22,8550 Zwevegem
- Power of attorney
- Power of attorney, Orinn Vijncke
16-06
Gazette deed
Appointment: Florian Demuynck (additional director)2 facts ▸
- General meeting, 27-04-2026
- Director appointment, Florian Demuynck (additional director)
27-06
Gazette deed
IncorporationAppointment: VAN DEN BERGE Wouter (director) · Founder · Shareholding12 facts ▸
- Founder, VAN DEN BERGE Wouter
- Incorporation, “Dr. Wouter Van den Berge” (deed in Dutch)
- Shareholding, 50
- Bank account, “bijzondere rekening namens vennootschap in oprichting”, 18-05-2024 (deed in Dutch)
- Founding capital, €1,000
- Registered office clause, “8870 Izegem,Bellevuestraat 13” (deed in Dutch)
- Pre-incorporation commitments, “takeover, verbintenissen voor rekening en ten name van vennootschap in oprichting binnen twee jaar voor neerlegging uittreksel” (deed in Dutch)
- Board rule, 1, “niet-statutaire bestuurders” (deed in Dutch)
- Director appointment, VAN DEN BERGE Wouter (director)
- Other provision, “geen bestuursverbod, niet getroffen door besluit dat zich verzet” (deed in Dutch)
- Other provision, 14-05-2024
- Other provision, 01-12-2024
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 24 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
2 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 34042B0290/00K000indicative | Flanders | 791 m² | 1 · 133 m² | 7.2 m · 2 |
| 36494D1008/00R003 | Flanders | 514 m² | - | - |
How the parcels are linked
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Dr. Wouter Van den Berge
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Één of meer bestuurders,natuurlijke personen, algemene vergadering kan mandaat steeds hernieuwen” (deed in Dutch)1 more provision on this in the deed
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Op naam, 50” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Friday of March at 20:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Ontbinding op elk moment door algemene vergadering, vereisten statutenwijziging” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Ontbinding en sluiting vereffening in één akte mogelijk, artikel 2:80 WVV” (deed in Dutch)“Beroep op artsen voor zaken persoonlijke levenssfeer patiënten en/of beroepsgeheim aandeelhouders, algemene vergadering kan te allen tijde…” (deed in Dutch)